We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
-7.88%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$176M
AUM Growth
-$25.8M
(-13%)
Cap. Flow
-$8.58M
Cap. Flow
% of AUM
-4.87%
Top 10 Holdings %
Top 10 Hldgs %
27.12%
Holding
88
New
7
Increased
8
Reduced
60
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baker Hughes
BKR
|
+$4.12M |
| 2 |
Lamar Advertising Co
LAMR
|
+$3.49M |
| 3 |
APTV.PRA
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
|
+$2.15M |
| 4 |
Intel
INTC
|
+$1.48M |
| 5 |
Newmont
NEM
|
+$1.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molson Coors Class B
TAP
|
+$6.18M |
| 2 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$3.77M |
| 3 |
Prudential Financial
PRU
|
+$2.78M |
| 4 |
Pfizer
PFE
|
+$1.2M |
| 5 |
PENN Entertainment
PENN
|
+$1.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.12% |
| 2 | Financials | 16.59% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Energy | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66B
| $6.43M | 3.66% |
85,011
-3,750
| -4% | -$300K |
|
2
Huntington Bancshares
HBAN
$35.1B
| $5.24M | 2.98% |
397,466
-20,787
| -5% | -$278K |
|
3
Devon Energy
DVN
$51.4B
| $5.13M | 2.91% |
85,299
-4,261
| -5% | -$265K |
|
4
EOG Resources
EOG
$77.6B
| $4.63M | 2.63% |
41,413
-1,760
| -4% | -$198K |
|
5
Tyson Foods
TSN
$21B
| $4.61M | 2.62% |
69,932
-3,616
| -5% | -$286K |
|
|
6
Newmont
NEM
$100B
| $4.6M | 2.62% |
109,483
+30,837
| +39% | +$1.44M |
|
7
Microsoft
MSFT
$3.62T
| $4.55M | 2.59% |
19,558
-744
| -4% | -$196K |
|
8
Blackrock
BLK
$175B
| $4.36M | 2.48% |
7,915
-393
| -5% | -$257K |
|
|
9
Intel
INTC
$459B
| $4.12M | 2.34% |
159,956
+43,475
| +37% | +$1.48M |
|
10
Johnson & Johnson
JNJ
$613B
| $4.05M | 2.3% |
24,778
-41
| -0.2% | -$6.94K |
|
11
Target
TGT
$67.8B
| $3.93M | 2.23% |
26,474
-1,075
| -4% | -$172K |
|
12
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $3.55M | 2.02% |
112,043
-1,770
| -2% | -$59.3K |
|
13
Invesco
IVZ
$13.6B
| $3.45M | 1.96% |
252,140
-7,420
| -3% | -$125K |
|
|
14
Baker Hughes
BKR
$60.4B
| $3.45M | 1.96% |
+164,647
| New | +$4.12M |
|
15
NetApp
NTAP
$35.9B
| $3.45M | 1.96% |
55,723
-3,275
| -6% | -$228K |
|
16
Citigroup
C
$224B
| $3.44M | 1.96% |
82,611
-3,083
| -4% | -$152K |
|
17
CVS Health
CVS
$134B
| $3.44M | 1.96% |
36,074
-1,712
| -5% | -$169K |
|
18
United Parcel Service
UPS
$90.8B
| $3.34M | 1.9% |
20,656
-1,427
| -6% | -$270K |
|
19
Viatris
VTRS
$20.5B
| $3.33M | 1.9% |
391,405
-14,773
| -4% | -$145K |
|
20
UnitedHealth
UNH
$377B
| $3.22M | 1.83% |
6,375
-428
| -6% | -$225K |
|
21
Ericsson
ERIC
$33.1B
| $3.2M | 1.82% |
557,935
-10,272
| -2% | -$73.6K |
|
|
22
Pfizer
PFE
$143B
| $3.14M | 1.78% |
71,684
-24,783
| -26% | -$1.2M |
|
|
23
Lamar Advertising Co
LAMR
$16B
| $3.02M | 1.72% |
+36,627
| New | +$3.49M |
|
24
MetLife
MET
$62B
| $2.95M | 1.68% |
48,508
-2,282
| -4% | -$146K |
|
25
IBM
IBM
$213B
| $2.83M | 1.61% |
23,835
-768
| -3% | -$101K |
|
Similar funds
MWM
PCC
CF
SGCM
RCWM
LCA
WHCI
FPWM
Palouse Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Palouse Capital Management held 88 positions worth $176M, down 13% from $202M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Palouse Capital Management withdrew a net $8.58M in Q3 2022, closing 10 positions and reducing 60 holdings. Its most notable exit was Molson Coors Class B, an estimated $6.18M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Palouse Capital Management opened a new position in Baker Hughes worth $3.45M.
- Palouse Capital Management's largest Q3 2022 buy was Baker Hughes: 164,647 shares worth $3.45M.
- Palouse Capital Management added most to Intel in Q3 2022, an estimated $1.48M increase.
- Palouse Capital Management's biggest Q3 2022 reduction was Pfizer, cutting an estimated $1.2M.
- Palouse Capital Management fully exited Molson Coors Class B in Q3 2022, selling an estimated $6.18M.
- Palouse Capital Management's ten largest holdings make up 27% of its $176M portfolio in Q3 2022.
- Palouse Capital Management opened 7 new positions and closed 10 in Q3 2022.
- Palouse Capital Management's portfolio value fell 13% quarter-over-quarter to $176M.
Based on Palouse Capital Management's 13F filing for Q3 2022, filed 21 Oct 2022.